Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Acquisitions (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Acquisitions for 7 consecutive years, with $7.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Acquisitions fell 29.58% to $7.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.2 million, a 29.78% decrease, with the full-year FY2025 number at $9.2 million, down 29.78% from a year prior.
  • Acquisitions was $7.6 million for Q4 2025 at Select Medical Holdings, up from $1.6 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $55.1 million in Q4 2021 to a low of -$3.7 million in Q3 2024.
  • A 5-year average of $8.9 million and a median of $5.9 million in 2021 define the central range for Acquisitions.
  • Peak YoY movement for Acquisitions: skyrocketed 2842.97% in 2021, then crashed 128.88% in 2024.
  • Select Medical Holdings' Acquisitions stood at $55.1 million in 2021, then plummeted by 91.0% to $5.0 million in 2022, then surged by 83.17% to $9.1 million in 2023, then grew by 18.72% to $10.8 million in 2024, then fell by 29.58% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Acquisitions are $7.6 million (Q4 2025), $1.6 million (Q3 2025), and $10.8 million (Q4 2024).